Cancer Research UK scientists have discovered that lung cancers can lie dormant for over 20 years before suddenly turning into an aggressive form of the disease, according to a study published recently.
The team studied lung cancers from seven patients – including smokers, ex-smokers, and never smokers. They found that after the first genetic mistakes that cause the cancer, it can exist undetected for many years until new, additional faults trigger rapid growth of the disease.
During this expansion there is a surge of different genetic faults appearing in separate areas of the tumor. Each distinct section evolves down different paths – meaning that every part of the tumor is genetically unique.
This research – jointly funded by Cancer Research UK and the Rosetrees Trust – highlights the need for better ways to detect the disease earlier. Two-thirds of patients are diagnosed with advanced forms of the disease when treatments are less likely to be successful.
By revealing that lung cancers can lie dormant for many years the researchers hope this study will help improve early detection of the disease.
Study author Professor Charles Swanton, at Cancer Research UK’s London Research Institute and the University College London (UCL) Cancer Institute, said: “Survival from lung cancer remains devastatingly low with many new targeted treatments making a limited impact on the disease. By understanding how it develops we’ve opened up the disease’s evolutionary rule book in the hope that we can start to predict its next steps.”
The study also highlighted the role of smoking in the development of lung cancer. Many of the early genetic faults are caused by smoking. But as the disease evolved these became less important with the majority of faults now caused by a new process generating mutations within the tumor controlled by a protein called APOBEC.
The wide variety of faults found within lung cancers explains why targeted treatments have had limited success. Attacking a particular genetic mistake identified by a biopsy in lung cancer will only be effective against those parts of the tumor with that fault, leaving other areas to thrive and take over.
Over 40,000 people are diagnosed with lung cancer each year and, despite some positive steps being made against the disease it remains one of the biggest challenges in cancer research, with fewer than 10 per cent surviving for at least 5 years after diagnosis.
Building on this research will be a key priority for the recently established Cancer Research UK Lung Cancer Centre of Excellence at Manchester and UCL. The Centre – where Professor Swanton is joint center lead – is a key part of Cancer Research UK’s renewed focus to beat lung cancer; bringing together a unique range of internationally renowned scientists and clinicians to create an environment that catalysts imaginative and innovative lung cancer research.
Professor Nic Jones, Cancer Research UK’s chief scientist, said: “This fascinating research highlights the need to find better ways to detect lung cancer earlier when it’s still following just one evolutionary path. If we can nip the disease in the bud and treat it before it has started travelling down different evolutionary routes we could make a real difference in helping more people survive the disease.”
“Building on this work Cancer Research UK is funding a study called TRACERx which is studying 100s of patient’s lung cancers as they evolve over time to find out exactly how lung cancers mutate, adapt, and become resistant to treatments ”
Illustration: Cancer Research UK.
Cancer Research UK News Release (10/09/14)
Science Daily (10/09/14)
Medical News Today (10/10/14)
Abstract (Science; Vol. 346, No. 6206, 251-256 (10/10/14))